Segment Reporting (Details) - Schedule of Segment Profitability That Are Most Relied Upon By the Codm Are Gross Revenues and Net Loss - USD ($) $ in Thousands	3 Months Ended	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2023
Dominari Securities [Member]
Segment Reporting Information [Line Items]
Revenue	$ 71	$ 71
Operating Costs
General and administrative	6,957	8,056
Loss from operations	(6,886)	(7,985)
Other (expenses) income
Interest income	44	44
Total other (expenses) income	44	44
Net loss	(6,842)	(7,941)
Legacy AIkido Pharma [Member]
Segment Reporting Information [Line Items]
Revenue
Operating Costs
General and administrative	2,123	4,857
Research and development	2	3
Loss from operations	(2,125)	(4,860)
Other (expenses) income
Other income
Interest income	116	253
Loss on marketable securities	400	335
Unrealized loss on note receivable	(212)	(212)
Total other (expenses) income	304	376
Net loss	(1,821)	(4,484)
Consolidated [Member]
Segment Reporting Information [Line Items]
Revenue	71	71
Operating Costs
General and administrative	9,080	12,913
Research and development	2	3
Loss from operations	(9,011)	(12,845)
Other (expenses) income
Other income
Interest income	160	297
Loss on marketable securities	400	335
Unrealized loss on note receivable	(212)	(212)
Total other (expenses) income	348	420
Net loss	$ (8,663)	$ (12,425)